Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 222-233
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.222
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.222
Adverse events | No. of patients (%) | No. of patients (%) | No. of patients (%) |
Immuno-related | Grade 1 | Grade 2 | Grade 3 |
Any | 4 (11.1) | 4 (11.1) | 2 (5.6) |
Dermatologic | |||
Rash | 2 (5.6) | 0 (0) | 0 (0) |
RCCEP | 1 (2.80) | 0 (0) | 0 (0) |
Endocrine | |||
Hypothyroidism | 2 (5.6) | 2 (5.6) | 1 (2.80) |
Hyperglycemia | 0 (0) | 0 (0) | 0 (0) |
Fatigue | 3 (8.3) | 4(11.1) | 0 (0) |
Surgery-related | |||
Any | 1 (2.80) | 4(11.1) | 1 (2.80) |
Chylous fistula | 0 (0) | 2 (5.6) | 0 (0) |
Anastomosis leakage | 0 (0) | 2 (5.6) | 0 (0) |
Fever | 1 (2.80) | 0 (0) | 0 (0) |
Intra-abdominal hemorrhage | 0 (0) | 0 (0) | 1 (2.80) |
- Citation: Li YJ, Liu XZ, Yao YF, Chen N, Li ZW, Zhang XY, Lin XF, Wu AW. Efficacy and safety of preoperative immunotherapy in patients with mismatch repair-deficient or microsatellite instability-high gastrointestinal malignancies. World J Gastrointest Surg 2023; 15(2): 222-233
- URL: https://www.wjgnet.com/1948-9366/full/v15/i2/222.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i2.222